Amyloid Beta Peptide Is an Endogenous Negative Allosteric Modulator of Leptin Receptor.
Neuroendocrinology
; 111(4): 370-387, 2021.
Article
in En
| MEDLINE
| ID: mdl-32335558
ABSTRACT
INTRODUCTION:
Metabolic dysfunction is now recognized as a pivotal component of Alzheimer's disease (AD), the most common dementia worldwide. However, the precise molecular mechanisms linking metabolic dysfunction to AD remain elusive.OBJECTIVE:
Here, we investigated the direct impact of soluble oligomeric amyloid beta (Aß) peptides, the main molecular hallmark of AD, on the leptin system, a major component of central energy metabolism regulation.METHODS:
We developed a new time-resolved fluorescence resonance energy transfer-based Aß binding assay for the leptin receptor (LepR) and studied the effect of Aß on LepR function in several in vitro assays. The in vivo effect of Aß on LepR function was studied in an Aß-specific AD mouse model and in pro-opiomelanocortin (POMC) neurons of the hypothalamic arcuate nucleus.RESULTS:
We revealed specific and high-affinity (Ki = 0.1 nM) binding of Aß to LepR. Pharmacological characterization of this interaction showed that Aß binds allosterically to the extracellular domain of LepR and negatively affects receptor function. Negative allosteric modulation of LepR by Aß was detected at the level of signaling pathways (STAT-3, AKT, and ERK) in vitroand in vivo. Importantly, the leptin-induced response of POMC neurons, key players in the regulation of metabolic function, was completely abolished in the presence of Aß.CONCLUSION:
Our data indicate that Aß is a negative allosteric modulator of LepR, resulting in impaired leptin action, and qualify LepR as a new and direct target of Aß oligomers. Preventing the interaction of Aß with LepR might improve both the metabolic and cognitive dysfunctions in AD condition.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arcuate Nucleus of Hypothalamus
/
Pro-Opiomelanocortin
/
Amyloid beta-Peptides
/
Leptin
/
Allosteric Regulation
/
Receptors, Leptin
/
Alzheimer Disease
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Neuroendocrinology
Year:
2021
Document type:
Article
Affiliation country:
France
Publication country:
CH
/
SUIZA
/
SUÍÇA
/
SWITZERLAND